Cemiplimab Improves Health-Related Quality of Life (HRQoL) and Reduces Pain in Patients with Advanced Cutaneous Squamous Cell Carcinoma (CSCC): Results from a Post Hoc Exploratory Analysis of a Phase 2 Clinical Trial. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 5, n. 1, p. s5, 2021. DOI: 10.25251/skin.5.supp.5. Disponível em: https://skin.dermsquared.com/skin/article/view/1157. Acesso em: 19 apr. 2025.